BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10404525)

  • 1. Differentiation between recurrent brain tumour and post-radiation necrosis: the value of 201Tl SPET versus 18F-FDG PET using a dual-headed coincidence camera--a pilot study.
    Stokkel M; Stevens H; Taphoorn M; Van Rijk P
    Nucl Med Commun; 1999 May; 20(5):411-7. PubMed ID: 10404525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Narrow interval dual phase 18F-FDG PET/CT: A practical approach for distinguishing tumor recurrence from radiation necrosis in brain metastasis.
    Aggarwal A; Aggarwal AK; Prakash S; Vile DJ; Aggarwal A
    Medicine (Baltimore); 2024 May; 103(18):e37789. PubMed ID: 38701250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential tractography and whole brain connectometry in primary motor area gliomas resection: A feasibility study.
    Figueredo LF; Mejía-Cordovez JA; Gomez-Amarillo DA; Hakim F; Pimienta-Redondo HD; Almeida JP; Kehayov I; Angelova P; Apostolov G; Luzzi S; Baldoncini M; Johnson JM; Ordóñez-Rubiano EG
    Clin Neurol Neurosurg; 2024 Jun; 241():108305. PubMed ID: 38713964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-ictal changes presenting as late pseudoprogression on MRI and PET in a patient with diffuse glioma: Case report and brief literature review.
    Nair SM; Sahu A; Dasgupta A; Puranik A; Gupta T
    Neuroradiol J; 2024 Apr; 37(2):229-233. PubMed ID: 37002537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying clinical predictors for considering brain FDG-PET imaging in patients with catatonia: A case-control study.
    Ghafouri M; Duque L; Rodriguez LP; Philbrick KL; Savica R; Pazdernik VK; Port JD; Rummans TA; Singh B
    Schizophr Res; 2024 May; 267():138-140. PubMed ID: 38537394
    [No Abstract]   [Full Text] [Related]  

  • 6. Umbrella review and network meta-analysis of diagnostic imaging test accuracy studies in Differentiating between brain tumor progression versus pseudoprogression and radionecrosis.
    Dagher R; Gad M; da Silva de Santana P; Sadeghi MA; Yewedalsew SF; Gujar SK; Yedavalli V; Köhler CA; Khan M; Tavora DGF; Kamson DO; Sair HI; Luna LP
    J Neurooncol; 2024 Jan; 166(1):1-15. PubMed ID: 38212574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Mount Fuji sign.
    Anandpara KM; Aswani Y; Hira P
    Clin Med (Lond); 2015 Dec; 15(6):596. PubMed ID: 26621958
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-invasive sensitive brain tumor detection using dual-modality bioimaging nanoprobe.
    Liu Y; Carpenter AB; Pirozzi CJ; Yuan H; Waitkus MS; Zhou Z; Hansen L; Seywald M; Odion R; Greer PK; Hawk T; Chin BB; Vaidyanathan G; Zalutsky MR; Yan H; Vo-Dinh T
    Nanotechnology; 2019 Jul; 30(27):275101. PubMed ID: 30856613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. To study the efficacy of thallium-201 as tumor seeking agent and to study its role in therapeutic response.
    Kumar AVSA; Kumar PG; Sampath S; Suhag V
    Med J Armed Forces India; 2017 Jul; 73(3):242-249. PubMed ID: 28790781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain 18F-FDG PET findings and sequential vestibular testing in SCA27B: a case report.
    Jiménez-Huete A; Patiño-García A; Guillén EF; Porta JM; Martin-Bastida A; Suárez-Vega V; Pérez N
    J Neurol; 2024 Feb; 271(2):1015-1018. PubMed ID: 37831126
    [No Abstract]   [Full Text] [Related]  

  • 11. Complications of Radiotherapy and Radiosurgery in the Brain and Spine.
    Barisano G; Bergamaschi S; Acharya J; Rajamohan A; Gibbs W; Kim P; Zada G; Chang E; Law M
    Neurographics (2011); 2018 Jun; 8(3):167-187. PubMed ID: 35388375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiological diagnosis of brain radiation necrosis after cranial irradiation for brain tumor: a systematic review.
    Furuse M; Nonoguchi N; Yamada K; Shiga T; Combes JD; Ikeda N; Kawabata S; Kuroiwa T; Miyatake SI
    Radiat Oncol; 2019 Feb; 14(1):28. PubMed ID: 30728041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ratio of HLA-DR and VNN2
    Soler DC; Young AB; Cooper KD; Kerstetter-Fogle A; Barnholtz-Sloan JS; Gittleman H; McCormick TS; Sloan AE
    J Neurooncol; 2017 Aug; 134(1):189-196. PubMed ID: 28551851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of optical spectroscopic methods in neuro-oncological sciences.
    Bahreini M
    J Lasers Med Sci; 2015; 6(2):51-61. PubMed ID: 25987969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology, diagnosis, and treatment of radiation necrosis in the brain.
    Miyatake S; Nonoguchi N; Furuse M; Yoritsune E; Miyata T; Kawabata S; Kuroiwa T
    Neurol Med Chir (Tokyo); 2015; 55(1):50-9. PubMed ID: 25744350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminating radiation necrosis from tumor progression in gliomas: a systematic review what is the best imaging modality?
    Shah AH; Snelling B; Bregy A; Patel PR; Tememe D; Bhatia R; Sklar E; Komotar RJ
    J Neurooncol; 2013 Apr; 112(2):141-52. PubMed ID: 23344789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, dosimetric, and radiographic correlation of radiation injury involving the brainstem and the medial temporal lobes following stereotactic radiotherapy for neoplasms of central skull base.
    Schipani S; Jain R; Shah K; Rock JP; Movsas B; Rosenblum M; Ryu S
    J Neurooncol; 2010 Jun; 98(2):177-84. PubMed ID: 20376551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment induced necrosis versus recurrent/progressing brain tumor: going beyond the boundaries of conventional morphologic imaging.
    Jain R; Narang J; Sundgren PM; Hearshen D; Saksena S; Rock JP; Gutierrez J; Mikkelsen T
    J Neurooncol; 2010 Oct; 100(1):17-29. PubMed ID: 20179990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities.
    Alexiou GA; Tsiouris S; Kyritsis AP; Voulgaris S; Argyropoulou MI; Fotopoulos AD
    J Neurooncol; 2009 Oct; 95(1):1-11. PubMed ID: 19381441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and metabolic predictors of chemosensitivity in oligodendroglial neoplasms.
    Walker C; Haylock B; Husband D; Joyce KA; Fildes D; Jenkinson MD; Smith T; Broome J; Kopitzki K; du Plessis DG; Prosser J; Vinjamuri S; Warnke PC
    Br J Cancer; 2006 Nov; 95(10):1424-31. PubMed ID: 17031404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.